Literature DB >> 34016127

Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.

Saeed Sharifi1, Bita Bakhshi2, Shahin Najar-Peerayeh1.   

Abstract

BACKGROUND: Campylobacter resistance to antimicrobial agents is regarded as a major concern worldwide. The aim of this study was to investigate the expression of the CmeABC efflux pump and the RAPD-PCR pattern in drug-resistant Campylobacter isolates.
METHODS: A total of 283 stool specimens were collected from children under the age of five with diarrhea. The minimum inhibitory concentration (MIC) of tetracycline and ciprofloxacin was determined by broth microdilution method and E-test, respectively. Detection of tetracycline and ciprofloxacin determinants was done by amplification of tetO gene and PCR-sequencing of the gyrA gene. The cmeABC transcriptional expression was analyzed by Real-time (RT)-PCR. Clonal correlation of resistant strains was determined by RAPD-PCR genotyping.
RESULTS: Out of 283 fecal samples, 20 (7.02%) samples were positive for Campylobacter spp. Analysis of duplex PCR assay of the cadF gene showed that 737 and 461 bp amplicons were corresponding to Campylobacter jejuni and Campylobacter coli, respectively. All of the 17 phenotypically tetracycline-resistant Campylobacter isolates harbored the tetO gene. Also, four phenotypically ciprofloxacin-resistant Campylobacter isolates had a point mutation at codon 257 of the gyrA gene (ACA to ATA; Thr > Ile). High-level expression of the cmeA gene was observed in ciprofloxacin-resistant and high-level tetracycline-resistant Campylobacter isolates, suggesting a positive correlation between the cmeA gene expression level and tetracycline resistance level. Moreover, a statistically significant difference was observed in the cmeA gene expression between ciprofloxacin-resistant and ciprofloxacin-susceptible strains, which signifies the crucial contribution of the efflux pump in conferring multiple drug resistance phenotype among Campylobacter spp. RAPD analysis of Campylobacter isolates exhibited 16 different patterns. Simpsone`s diversity index of RAPD-PCR was calculated as 0.85, showing a high level of homogeneity among the population; however, no clear correlation was detected among tetracycline and/or ciprofloxacin resistant isolates.
CONCLUSION: Significant contribution of the CmeABC efflux pump in conferring high-level resistance to tetracycline and ciprofloxacin was observed in C. jejuni and C. coli clinical isolates. The resistant phenotype is suggested to be mediated by CmeABC efflux pumps, the tetO gene, and point mutation of the gyrA gene. Genotyping revealed no clonal correlation among resistant strains, indicating distinct evolution of tetracycline and ciprofloxacin resistant genotypes among the isolates.

Entities:  

Keywords:  Antibiotic resistance; Campylobacter; Efflux pump; RAPD-PCR; RT-PCR

Year:  2021        PMID: 34016127     DOI: 10.1186/s12941-021-00439-6

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


  41 in total

Review 1.  Guillain-Barré syndrome.

Authors:  Richard A C Hughes; David R Cornblath
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

2.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 3.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

4.  Nosocomial outbreak of Campylobacter jejuni meningitis in newborn infants.

Authors:  H Goossens; G Henocque; L Kremp; J Rocque; R Boury; G Alanio; L Vlaes; W Hemelhof; C Van den Borre; M Macart
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

Review 5.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence.

Authors:  Taradon Luangtongkum; Byeonghwa Jeon; Jing Han; Paul Plummer; Catherine M Logue; Qijing Zhang
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

6.  Molecular typing of Campylobacter jejuni isolates involved in a neonatal outbreak indicates nosocomial transmission.

Authors:  José Llovo; Estíbaliz Mateo; Angeles Muñoz; María Urquijo; Stephen L W On; Aurora Fernández-Astorga
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

7.  Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.

Authors:  Bernadeta Szczepanska; Małgorzata Andrzejewska; Dorota Spica; Jacek J Klawe
Journal:  BMC Microbiol       Date:  2017-04-04       Impact factor: 3.605

8.  Increased risk for Campylobacter jejuni and C. coli infection of pet origin in dog owners and evidence for genetic association between strains causing infection in humans and their pets.

Authors:  L Mughini Gras; J H Smid; J A Wagenaar; M G J Koene; A H Havelaar; I H M Friesema; N P French; C Flemming; J D Galson; C Graziani; L Busani; W VAN Pelt
Journal:  Epidemiol Infect       Date:  2013-02-28       Impact factor: 4.434

9.  Transmission OF Campylobacter coli in chicken embryos.

Authors:  Daise Aparecida Rossi; Belchiolina Beatriz Fonseca; Roberta Torres de Melo; Gutembergue da Silva Felipe; Paulo Lourenço da Silva; Eliane Pereira Mendonça; Ana Luzia Lauria Filgueiras; Marcelo Emilio Beletti
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

Review 10.  Campylobacter: from microbiology to prevention.

Authors:  A Facciolà; R Riso; E Avventuroso; G Visalli; S A Delia; P Laganà
Journal:  J Prev Med Hyg       Date:  2017-06
View more
  2 in total

Review 1.  Two-component regulatory systems in Helicobacter pylori and Campylobacter jejuni: Attractive targets for novel antibacterial drugs.

Authors:  Javier Casado; Ángel Lanas; Andrés González
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

Review 2.  Antibiotic Resistance in Bacteria-A Review.

Authors:  Renata Urban-Chmiel; Agnieszka Marek; Dagmara Stępień-Pyśniak; Kinga Wieczorek; Marta Dec; Anna Nowaczek; Jacek Osek
Journal:  Antibiotics (Basel)       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.